Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Med Genet. 2002 Oct 30;115(3):183-8.

Cytogenetics and molecular genetics of lung cancer.

Author information

  • 1Fox Chase Cancer Center in Philadelphia, Pennsylvania 19111, USA.

Abstract

The development and progression of lung cancer is a multistep process characterized by the accumulation of numerous genetic and epigenetic alterations, some of which occur early in the course of disease. In this review, we summarize cytogenetic imbalances and molecular genetic/epigenetic changes seen in human small-cell and non-small-cell lung cancer. Alterations of tumor suppressor genes and oncogenes leading to perturbations of key cell-regulatory and growth-control pathways are highlighted. The translational implications of molecular biomarkers for risk assessment, early detection, and monitoring of chemoprevention trials are discussed.

Copyright 2002 Wiley-Liss, Inc.

PMID:
12407699
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk